WO2006049926A1 - Expandable fixation mechanism - Google Patents

Expandable fixation mechanism Download PDF

Info

Publication number
WO2006049926A1
WO2006049926A1 PCT/US2005/038157 US2005038157W WO2006049926A1 WO 2006049926 A1 WO2006049926 A1 WO 2006049926A1 US 2005038157 W US2005038157 W US 2005038157W WO 2006049926 A1 WO2006049926 A1 WO 2006049926A1
Authority
WO
WIPO (PCT)
Prior art keywords
expandable element
hydrogel
perimeter
expandable
coupled
Prior art date
Application number
PCT/US2005/038157
Other languages
French (fr)
Inventor
Carole A. Tronnes
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic, Inc. filed Critical Medtronic, Inc.
Publication of WO2006049926A1 publication Critical patent/WO2006049926A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • A61N1/0558Anchoring or fixation means therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37518Anchoring of the implants, e.g. fixation

Definitions

  • the invention relates to implantable medical devices implantable in a human or animal body and, more particularly, fixation structures for securing implantable medical devices.
  • Implantable medical devices include components that are deployed in particular areas within a human or animal body.
  • a neurostimulator deployed proximate to targeted tissue includes electrodes that deliver an electrical stimulation therapy to the tissue.
  • an electrical sensor deployed proximate to a muscle senses activation of the muscle.
  • Fixation structures can anchor a medical device to an anatomical feature, such as an organ or a bone. Fixation structures do not necessarily restrict all motion of the implanted device or its component, but generally reduce the motion of the device or component so that it remains proximate to a target site.
  • the invention is directed to fixation structures for medical devices implantable in a human or animal body, as well as medical devices incorporating such fixation structures.
  • Such devices can include neurostimulators, sensors, electrodes, and the like.
  • When the devices are implanted it is generally desirable that migration of an implanted device be restricted.
  • the invention presents easily implantable devices that help reduce migration.
  • Various embodiments of the present invention provide solutions to one or more problems existing in the prior art with respect to fixation mechanisms for implantable medical devices. These problems include the migration of medical devices from a desired implantation site. An additional problem is the reduced therapeutic efficacy that may result when a medical device migrates from its intended implantation site. Additional problems relate to the time and skill required in placement of conventional fixation mechanisms, such as sutures.
  • an implantable device includes a non-expandable element and one or more expandable elements.
  • the expandable elements are constructed of a hydrogel material.
  • the expandable elements are in a dehydrated state, in which the expandable elements are smaller. But when implanted in the body of a patient, the expandable elements absorb water from the body tissues and assume a hydrated state. In the hydrated state, the expandable elements have a larger perimeter. Expansion of the expandable elements resists migration of the implanted device.
  • the invention can provide fixation for a variety of medical devices, including but not limited to self-contained stimulators and lead-mounted electrodes, without the need for sutures or other mechanisms requiring surgical placement. Rather, the fixation mechanism is generally self-deploying. In addition, the invention provides for a small profile during implantation, allowing implantation to be made by less invasive techniques.
  • FIG. 1 is a perspective view of an expandable device in a dehydrated state according to an embodiment of the invention.
  • FIG. 2 is a perspective view of the device of FIG. 1 in a hydrated state.
  • FIG. 3 is a cross section of an exemplary syringe that may be used to implant a device such as the device depicted in FIG. 1.
  • FIG. 4 is a cross section of a tissues that have received devices in a dehydrated state, according to two embodiments of the invention.
  • FIG. 5 a cross section of the tissues of FIG. 4, with the devices in hydrated states.
  • FIG. 6 is a perspective view of another expandable device in a dehydrated state according to an embodiment of the invention.
  • FIG. 7 is a perspective view of the device of FIG. 6 in a hydrated state.
  • FIG. 8 is a block diagram of an implantable stimulator according to an embodiment of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 depicts an exemplary medical device 10 configured to be implanted in a human or animal body.
  • a self-contained device such as a microstimulator or a sensor.
  • the microstimulator may be a neurostimulator or muscle stimulator.
  • the sensor may be configured to sense a variety of conditions, such as pressure, flow, temperature, fluid level, contractile force, pH, chemical concentration, or the like.
  • Medical device 10 is self-contained in that it is not physically coupled to any other medical device by a lead or other connection. Medical device 10 can, for example, receive power from or wirelessly communicate with an external control device. In another embodiment, medical device 10 operates with an internal power supply.
  • the invention is not limited to any particular medical device. Nor is the invention limited to self-contained medical devices, but encompasses medical devices that include leads or that are otherwise not self-contained.
  • Exemplary medical device 10 is shown in FIG. 1 in a first, miniature configuration.
  • Exemplary medical device 10 is shown in FIG. 2 in a second, expanded configuration.
  • medical device 10 has a shape similar to that of a capsule or a grain of rice.
  • medical device 10 has a shape similar to that of a dumbbell.
  • Medical device 10 includes two expandable elements 12 and 14, which are constructed of a biocompatible hydrogel material. Hydrogel materials that are believed to have wide applicability are the polyacrylonitrile copolymers as described in U.S. Pat. Nos. 4,943,618 and 5,252,692, which are incorporated herein by reference. By controlling relative amounts of copolymers, it is often possible to regulate physical qualities of the hydrogel such as flexibility and amount of expansion.
  • hydrogels can assume a dehydrated state and a hydrated state.
  • a hydrogel element in its dehydrated state is generally substantially smaller than the element in its hydrated state.
  • a hydrogel element in its dehydrated state when implanted in the body of a patient and placed in contact with body fluids, absorbs water and expands, assuming a hydrated state.
  • the capsule shaped device shown in FIG. 1 becomes the dumbbell shaped device shown in FIG. 2 when device 10 is implanted in the body of a patient and comes in contact with bodily fluids.
  • the composition of the hydrogel in expandable elements 12 and 14 and the amount of fluid it may take expandable elements 12 and 14 from a few minutes to a few hours to expand.
  • Medical device 10 includes a non-expandable element 16 that may be constructed from any biocompatible material such as polyurethane or silicone.
  • Non-expandable element 16 may take the form of a housing, which may be constructed from any of a variety of biocompatible materials such as silicone, polyurethane, titanium, stainless steel, fluoropolymer and hydrogel.
  • non-expandable element 16 is elongated and substantially cylindrical, and provides a platform for sensing or stimulating elements, depicted in FIGS. 1 and 2 as electrodes 18 and 20.
  • medical device 10 may have any of a variety of shapes and sizes.
  • non- expandable element 16 can serve as a housing for any electronic or other internal components of medical device 10.
  • non-expandable element 16 can house components such as a pulse generator, a wireless telemetry interface, a power supply and a processor that controls delivery of stimulations.
  • Expandable elements 12 and 14 can be coupled to non-expandable element 16 in any manner, such as by adhesive or by shaping expandable elements 12 and 14 to lock with non-expandable element 16. As shown in FIGS. 1 and 2, expandable elements 12 and 14 can be deployed on the ends of non-expandable element 16, but the invention encompasses embodiments in which the expandable elements are deployed elsewhere.
  • the dimensions of device 10 can be selected such that device 10 can fit inside the bore of an insertion device, such as needle, hollow trocar, endoscope, catheter or cannula.
  • an insertion device such as needle, hollow trocar, endoscope, catheter or cannula.
  • device 10 can fit through an sleeve oriented substantially parallel to long axis 22.
  • Dimensions of implant 10 in the dehydrated state can be approximately one to seven millimeters in diameter (transverse to axis 22) and approximately ten to twenty millimeters in length (parallel to axis 22).
  • the invention encompasses other shapes and dimensions as well.
  • the dimensions of medical device 10 can depend upon the internal components of medical device 10.
  • the invention encompasses various shapes and dimensions of expandable elements 12 and 14.
  • the diameter of expandable elements 12 and 14 in the dehydrated state can be comparable to the diameter of non-expandable element 16. While in the expanded state, by contrast, the diameter of expandable elements 12 and can be at least approximately two times, and more preferably at least approximately three times the diameter of non-expandable element 16. Expandable elements 12 and 14 swell radially. That is, expandable elements 12 and 14, expand outward from axis 22. While in the dehydrated state, expandable elements 12 and 14 have a small perimeter, but in the hydrated state, expandable elements 12 and 14 have a larger perimeter. As noted above, the degree of expansion can be regulated.
  • the hydrogel can be configured, for example, to expand approximately two to five times when hydrating.
  • FIGS. 1 and 2 show a medical device having one non-expandable element and two expandable elements.
  • the invention encompasses embodiments that include multiple non-expandable elements and multiple expandable elements.
  • medical device 10 is not directionally specific, and would function the same way when turned end for end.
  • the invention encompasses embodiments, however, in which the medical device is directionally specific.
  • the invention encompasses, for example, a medical device that has a larger expandable element on its proximal end and a smaller expandable element on its distal end.
  • FIG. 3 is a cross-sectional diagram of a device 30 that can implant a medical device such as medical device 10 in a patient.
  • Device 30 comprises a syringe, which includes a plunger member 32, a body member 34 and a hollow needle 36 having a lumen 38. Needle 36 is fixedly coupled to body member 34, while plunger member 32 is free to move in lumen 38. Lumen 38 of needle 36 has been enlarged to show medical device 10, in a miniature configuration with hydrogel elements in the dehydrated state, disposed in lumen 38.
  • medical device 10 in the miniaturized configuration is an elongated, substantially rice-shaped device, and sized to fit inside lumen 38.
  • Distal end 40 of needle 36 includes a sharp point that can pierce tissue such as the skin, the mucosa of the gastrointestinal tract, a body organ or a tissue mass. Distal end 40 further includes an opening through which medical device 10 may be expelled from lumen 38 by depressing plunger member 32 with respect to body member 34.
  • Device 30 is not the only device that can be used to implant a medical device such as medical device 10.
  • a physician can implant medical device 10 by making an incision in the skin, introducing an insertion device such as a catheter into the body of the patient, guiding the insertion device to a target site, pushing medical device 10 through the insertion device, and withdrawing the insertion device.
  • implantation of a medical device in a miniature configuration is less invasive than a surgical procedure to implant a the medical device in its enlarged configuration.
  • the medical device can be delivered to a target site in a miniature configuration, and expand on its own to its enlarged configuration.
  • a fluid can be injected into the implantation site to accelerate expansion.
  • FIGS. 4 and 5 are cross-sections of neighboring tissue layers 50 and 52. As depicted in FIGS. 4 and 5, tissue layers 50 and 52 are separated by a boundary 54, such as bone or fascia. FIGS. 4 and 5 depict deployment of medical device 10 from FIGS. 1 and 2. Medical device 10 is shown deployed with expandable element 12 in tissue layer 50, and expandable element 14 in tissue layer 52. Boundary 54 can be less resilient than tissue layers 50 and 52, and can prevent passage of expandable elements 12 and 14 in their enlarged, hydrated states, thereby reducing migration of medical device 10. For example, when boundary 54 represents the sacrum, medical device 10 can be deployed through a sacral foramen, and expandable elements 12 and 14 can prevent medical device 10 from migrating from the foramen. Deployed in such as fashion, electrodes 18 and 20 deployed on medical device 10 can be configured to sense or stimulate sacral nerves, e.g., for neurostimluation therapy for sexual dysfunction or urinary or fecal incontinence.
  • sacral nerves
  • FIGS. 4 and 5 also depict deployment of medical device 60, which is another embodiment of the invention.
  • Medical device 60 is similar to medical device 10 in some respects.
  • Medical device 10 includes one non-expandable element 16 and two expandable elements 12 and 14, and medical device 60 includes two non-expandable elements 62 and 64, with three expandable elements 66, 68 and 70.
  • medical device 60 is substantially cylindrical. As shown in FIGS. 4 and 5, however, medical device 60 defines a smaller diameter than medical device 10. Medical device 60 can be deployed through a catheter, a cannula or other medical instruments.
  • expandable elements 66, 68 and 70 have expanded to a hydrated state when placed in contact with the body fluids present in the tissues.
  • Expandable elements 66, 68 and 70 may be, but need not be, the same size as one another when in the hydrated state.
  • expandable element 70 when in the hydrated state, is smaller than expandable elements 66, and 68.
  • Expandable elements 68 and 70 can include central apertures to permit passage of electrical components such as lead wires.
  • the materials used to make medical device 60 may be the same as the materials used to make medical device 10.
  • first non- expandable element 62 may be constructed of a first material, such as polyurethane
  • second non-expandable element 64 may be constructed from a second material, such as silicone
  • Medical device 60 includes a lead 74.
  • Lead 74 can be coupled to non-expandable element 64 through a central aperture in expandable element 70.
  • Lead 74 includes one or more conductors that are electrically coupled to electrodes 76, 78, 80 and 82.
  • the conductors can further be electrically coupled to an implantable medical device (not shown).
  • an implantable medical device is an implantable pulse generator, which generates stimulating pulses.
  • the stimulating pulses can be delivered to tissue via electrodes 76, 78, 80 and 82.
  • Another example of such an implantable medical device is a sensor that senses electrical parameters, temperature, or other physiological aspects.
  • FIGS. 6 and 7 depict another embodiment of an exemplary medical device 90 configured to be implanted in a human or animal body.
  • Medical device 90 is similar to medical device 10 shown in FIGS. 1 and 2, in that medical device 90 includes an elongated non-expandable element 92 and two expandable elements 94 and 96.
  • medical device 90 also includes stimulating elements such as electrodes 98 and 100.
  • the materials used to make medical device 10 could also be used to make medical device 90.
  • Exemplary medical device 90 is shown in FIG. 6 in a miniature configuration, and is shown in FIG. 7 in an expanded configuration.
  • medical device 90 has a shape and dimensions comparable to that of a medical device 10 shown in FIG. 1.
  • expandable elements 94 and 96 When implanted in a body of a patient, expandable elements 94 and 96 swell radially when placed in contact with bodily fluids, and device 90 assumes an expanded configuration.
  • expandable elements 94 and 96 have a larger perimeter, giving medical device 90 a modified dumbbell shape.
  • Expandable elements 94 and 96 include a plurality of projections 102, 104 separated by gaps.
  • Expandable elements 94 and 96 can be prepared in a number of ways. One technique is to shape expandable elements 94 and 96 when expandable elements 94 and 96 are in the expanded hydrated state, then desiccate expandable elements 94 and 96 to put them in a dehydrated state and thereby reduce their size. Molding and cutting are two exemplary techniques for shaping expandable elements 94 and 96.
  • gaps between projections 102, 104 can facilitate flow of fluid in some deployments.
  • cells such as fibroblasts and fibrous tissue can occupy the gaps, thereby anchoring expandable elements 94 and 96 more firmly.
  • FIG. 8 is a block diagram of an exemplary medical device 110 that can employ many of the features described above.
  • Medical device 110 is an example of a self- contained implantable stimulator.
  • Stimulator 110 includes pulse generator 112, which supplies electrical stimulations to the target tissue via electrodes 114, 116, which are exposed to the tissue.
  • Pulse generator 112 supplies stimulations under the direction of processor 118.
  • Processor 118 may comprise a microprocessor, application specific integrated circuit, a programmable logic chip, or other controlling circuitry.
  • a power supply 120 such as a capacitor or a battery, supplies power to pulse generator 112 and processor 1 18.
  • medical device 110 includes an inductive coil 122 configured to receive energy from an external energy source.
  • Medical device 1 10 also includes a wireless telemetry interface 124 configured to wirelessly transmit or receive data or instructions.
  • Pulse generator 112, processor 118, power supply 120, coil 122 and wireless telemetry interface 124 are housed inside non- expandable element 126.
  • Expandable elements 128, 130 expand from a dehydrated state to a hydrated state when medical device 1 10 is implanted in the body of a patient. Expansion of expandable elements 128, 130 restricts migration of medical device 110. As a result, electrodes 114, 116 tend to remain proximate to the target tissue.
  • Medical device 110 can include components other than or in addition to the components depicted in FIG. 8.
  • medical device 1 10 can incorporate an accelerometer or a sensor, such as a sensor configured to sense conditions such as pressure, flow, temperature, fluid level, contractile force, pH or chemical concentration.
  • a sensor configured to sense conditions such as pressure, flow, temperature, fluid level, contractile force, pH or chemical concentration. The invention is not limited to the specific embodiment depicted in FIG. 8.
  • FIG. 8 depicts electronic components such as electrodes as housed inside non-expandable element 126.
  • the invention also supports embodiments in which one or more components are deployed on or in expandable elements 128, 130.
  • an electrode can be deployed on the surface of an expandable element such that the electrode moves away from non-expandable element 126 when the expandable element expands.
  • the invention is not limited to the particular shapes of expandable elements depicted in the figures. As shown in FIGS. 1, 2, 6 and 7, the expandable elements have substantially circular perimeters, and the perimeters expand as the expandable elements assume the hydrated state. In some embodiments, the perimeters of the expandable elements can by substantially elliptical or triangular, for example. In addition, the invention encompasses embodiments in which the expandable elements expand further in one direction than in another. The invention also encompasses embodiments in which one or more expandable element is folded or rolled to reduce its profile in the dehydrated state. As such an expandable element expands, the expandable element automatically unfolds or unrolls.
  • the invention is described as useful in application with the neurostimulation, the invention is not limited to that application. Furthermore, the invention can be deployed via implantation techniques in addition to those described above. The invention further includes within its scope methods of making and using the implants described above.

Abstract

In general, the invention is directed to a medical device implantable in a body of a patient. The device includes a housing with a plurality of collapsible fixation structures coupled to the housing, and can be in a collapsed configuration or an expanded configuration. The device assumes a collapsed configuration when in the bore of an insertion device, and assumes the expanded configuration when expelled from the insertion device into the body of the patient. The extended fixation structures engage the tissues in the body and restrict migration. One exemplary application of the invention is in the context of a microstimulator, with a pulse generator housed in the housing and one or more electrodes coupled to the housing. The fixation structures help keep the electrodes proximate to the tissues that are to receive the stimulation.

Description

EXPANDABLE FIXATION STRUCTURES
FIELD OF THE INVENTION
The invention relates to implantable medical devices implantable in a human or animal body and, more particularly, fixation structures for securing implantable medical devices.
BACKGROUND
Many implantable medical devices include components that are deployed in particular areas within a human or animal body. In one example, a neurostimulator deployed proximate to targeted tissue includes electrodes that deliver an electrical stimulation therapy to the tissue. In another example, an electrical sensor deployed proximate to a muscle senses activation of the muscle. With these and other implantable devices, it can be desirable that one or more components remain substantially anchored, so that the components will be less likely to migrate from the desired site of sensing or therapy.
Devices that restrict migration of an implanted medical device or a component thereof are called "fixation structures." Fixation structures can anchor a medical device to an anatomical feature, such as an organ or a bone. Fixation structures do not necessarily restrict all motion of the implanted device or its component, but generally reduce the motion of the device or component so that it remains proximate to a target site.
There have been many approaches that address fixation of medical devices. Some devices, such as a lead described in U.S. Pat. No. 4,269,198 to Stokes, employ fixed protrusions such as tines to engage body tissue. Other devices, such as the electrode assembly disclosed in U.S. Pat. No. 6,704,605 to Soltis et al., use a helical securing structure. U.S. Pat. No. 5,405,367 to Schulman et al. describes the use of barbs to hold a medical device such as a microstimulator in place.
Table 1 below lists documents that disclose some of the many devices and techniques pertaining fixation of medical devices. Some of the devices and techniques employ mechanical fixation structures such as tines or swellable membranes. Others employ adhesive properties to hold devices in place. TABLE 1
Figure imgf000003_0001
All documents listed in Table 1 above are hereby incorporated by reference herein in their respective entireties. As those of ordinary skill in the art will appreciate readily upon reading the Summary of the Invention, Detailed Description of the Preferred Embodiments and Claims set forth below, many of the devices and methods disclosed in the patents of Table 1 may be modified advantageously by using the techniques of the present invention.
SUMMARY OF THE INVENTION
In general, the invention is directed to fixation structures for medical devices implantable in a human or animal body, as well as medical devices incorporating such fixation structures. Such devices can include neurostimulators, sensors, electrodes, and the like. When the devices are implanted, it is generally desirable that migration of an implanted device be restricted. The invention presents easily implantable devices that help reduce migration.
Various embodiments of the present invention provide solutions to one or more problems existing in the prior art with respect to fixation mechanisms for implantable medical devices. These problems include the migration of medical devices from a desired implantation site. An additional problem is the reduced therapeutic efficacy that may result when a medical device migrates from its intended implantation site. Additional problems relate to the time and skill required in placement of conventional fixation mechanisms, such as sutures.
Various embodiments of the present invention are capable of solving at least one of the foregoing problems. In one exemplary embodiment, an implantable device includes a non-expandable element and one or more expandable elements. The expandable elements are constructed of a hydrogel material. During implantation, the expandable elements are in a dehydrated state, in which the expandable elements are smaller. But when implanted in the body of a patient, the expandable elements absorb water from the body tissues and assume a hydrated state. In the hydrated state, the expandable elements have a larger perimeter. Expansion of the expandable elements resists migration of the implanted device.
In comparison to known fixation mechanisms, various embodiments of the invention may provide one or more advantages. The invention can provide fixation for a variety of medical devices, including but not limited to self-contained stimulators and lead-mounted electrodes, without the need for sutures or other mechanisms requiring surgical placement. Rather, the fixation mechanism is generally self-deploying. In addition, the invention provides for a small profile during implantation, allowing implantation to be made by less invasive techniques.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of an expandable device in a dehydrated state according to an embodiment of the invention.
FIG. 2 is a perspective view of the device of FIG. 1 in a hydrated state.
FIG. 3 is a cross section of an exemplary syringe that may be used to implant a device such as the device depicted in FIG. 1.
FIG. 4 is a cross section of a tissues that have received devices in a dehydrated state, according to two embodiments of the invention.
FIG. 5 a cross section of the tissues of FIG. 4, with the devices in hydrated states.
FIG. 6 is a perspective view of another expandable device in a dehydrated state according to an embodiment of the invention.
FIG. 7 is a perspective view of the device of FIG. 6 in a hydrated state.
FIG. 8 is a block diagram of an implantable stimulator according to an embodiment of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
FIG. 1 depicts an exemplary medical device 10 configured to be implanted in a human or animal body. For purposes of illustration, FIG. 1 depicts a self-contained device such as a microstimulator or a sensor. The microstimulator may be a neurostimulator or muscle stimulator. The sensor may be configured to sense a variety of conditions, such as pressure, flow, temperature, fluid level, contractile force, pH, chemical concentration, or the like. Medical device 10 is self-contained in that it is not physically coupled to any other medical device by a lead or other connection. Medical device 10 can, for example, receive power from or wirelessly communicate with an external control device. In another embodiment, medical device 10 operates with an internal power supply. The invention is not limited to any particular medical device. Nor is the invention limited to self-contained medical devices, but encompasses medical devices that include leads or that are otherwise not self-contained.
Exemplary medical device 10 is shown in FIG. 1 in a first, miniature configuration. Exemplary medical device 10 is shown in FIG. 2 in a second, expanded configuration. In the first configuration, medical device 10 has a shape similar to that of a capsule or a grain of rice. In the second configuration, medical device 10 has a shape similar to that of a dumbbell. Medical device 10 includes two expandable elements 12 and 14, which are constructed of a biocompatible hydrogel material. Hydrogel materials that are believed to have wide applicability are the polyacrylonitrile copolymers as described in U.S. Pat. Nos. 4,943,618 and 5,252,692, which are incorporated herein by reference. By controlling relative amounts of copolymers, it is often possible to regulate physical qualities of the hydrogel such as flexibility and amount of expansion.
In general, hydrogels can assume a dehydrated state and a hydrated state. A hydrogel element in its dehydrated state is generally substantially smaller than the element in its hydrated state. A hydrogel element in its dehydrated state, when implanted in the body of a patient and placed in contact with body fluids, absorbs water and expands, assuming a hydrated state.
In this way, the capsule shaped device shown in FIG. 1 becomes the dumbbell shaped device shown in FIG. 2 when device 10 is implanted in the body of a patient and comes in contact with bodily fluids. Depending upon the composition of the hydrogel in expandable elements 12 and 14, and the amount of fluid, it may take expandable elements 12 and 14 from a few minutes to a few hours to expand.
Medical device 10 includes a non-expandable element 16 that may be constructed from any biocompatible material such as polyurethane or silicone. Non-expandable element 16 may take the form of a housing, which may be constructed from any of a variety of biocompatible materials such as silicone, polyurethane, titanium, stainless steel, fluoropolymer and hydrogel. In the embodiment shown in FIGS. 1 and 2, non-expandable element 16 is elongated and substantially cylindrical, and provides a platform for sensing or stimulating elements, depicted in FIGS. 1 and 2 as electrodes 18 and 20. However, medical device 10 may have any of a variety of shapes and sizes. In addition, non- expandable element 16 can serve as a housing for any electronic or other internal components of medical device 10. When medical device 10 is a self-contained stimulator, for example, non-expandable element 16 can house components such as a pulse generator, a wireless telemetry interface, a power supply and a processor that controls delivery of stimulations.
Expandable elements 12 and 14 can be coupled to non-expandable element 16 in any manner, such as by adhesive or by shaping expandable elements 12 and 14 to lock with non-expandable element 16. As shown in FIGS. 1 and 2, expandable elements 12 and 14 can be deployed on the ends of non-expandable element 16, but the invention encompasses embodiments in which the expandable elements are deployed elsewhere.
When expandable elements 12 and 14 are in the dehydrated state, and device 10 is in a miniature configuration, the dimensions of device 10 can be selected such that device 10 can fit inside the bore of an insertion device, such as needle, hollow trocar, endoscope, catheter or cannula. In particular, device 10 can fit through an sleeve oriented substantially parallel to long axis 22. Dimensions of implant 10 in the dehydrated state can be approximately one to seven millimeters in diameter (transverse to axis 22) and approximately ten to twenty millimeters in length (parallel to axis 22). The invention encompasses other shapes and dimensions as well. The dimensions of medical device 10 can depend upon the internal components of medical device 10.
The invention encompasses various shapes and dimensions of expandable elements 12 and 14. As shown in FIGS. 1 and 2, the diameter of expandable elements 12 and 14 in the dehydrated state can be comparable to the diameter of non-expandable element 16. While in the expanded state, by contrast, the diameter of expandable elements 12 and can be at least approximately two times, and more preferably at least approximately three times the diameter of non-expandable element 16. Expandable elements 12 and 14 swell radially. That is, expandable elements 12 and 14, expand outward from axis 22. While in the dehydrated state, expandable elements 12 and 14 have a small perimeter, but in the hydrated state, expandable elements 12 and 14 have a larger perimeter. As noted above, the degree of expansion can be regulated. The hydrogel can be configured, for example, to expand approximately two to five times when hydrating.
FIGS. 1 and 2 show a medical device having one non-expandable element and two expandable elements. As discussed below, the invention encompasses embodiments that include multiple non-expandable elements and multiple expandable elements. As depicted in FIGS. 1 and 2, medical device 10 is not directionally specific, and would function the same way when turned end for end. The invention encompasses embodiments, however, in which the medical device is directionally specific. The invention encompasses, for example, a medical device that has a larger expandable element on its proximal end and a smaller expandable element on its distal end.
FIG. 3 is a cross-sectional diagram of a device 30 that can implant a medical device such as medical device 10 in a patient. Device 30 comprises a syringe, which includes a plunger member 32, a body member 34 and a hollow needle 36 having a lumen 38. Needle 36 is fixedly coupled to body member 34, while plunger member 32 is free to move in lumen 38. Lumen 38 of needle 36 has been enlarged to show medical device 10, in a miniature configuration with hydrogel elements in the dehydrated state, disposed in lumen 38. As depicted in FIG. 2, medical device 10 in the miniaturized configuration is an elongated, substantially rice-shaped device, and sized to fit inside lumen 38.
Distal end 40 of needle 36 includes a sharp point that can pierce tissue such as the skin, the mucosa of the gastrointestinal tract, a body organ or a tissue mass. Distal end 40 further includes an opening through which medical device 10 may be expelled from lumen 38 by depressing plunger member 32 with respect to body member 34.
Device 30 is not the only device that can be used to implant a medical device such as medical device 10. For example, a physician can implant medical device 10 by making an incision in the skin, introducing an insertion device such as a catheter into the body of the patient, guiding the insertion device to a target site, pushing medical device 10 through the insertion device, and withdrawing the insertion device. In general, implantation of a medical device in a miniature configuration is less invasive than a surgical procedure to implant a the medical device in its enlarged configuration. The medical device can be delivered to a target site in a miniature configuration, and expand on its own to its enlarged configuration. In some cases, a fluid can be injected into the implantation site to accelerate expansion.
FIGS. 4 and 5 are cross-sections of neighboring tissue layers 50 and 52. As depicted in FIGS. 4 and 5, tissue layers 50 and 52 are separated by a boundary 54, such as bone or fascia. FIGS. 4 and 5 depict deployment of medical device 10 from FIGS. 1 and 2. Medical device 10 is shown deployed with expandable element 12 in tissue layer 50, and expandable element 14 in tissue layer 52. Boundary 54 can be less resilient than tissue layers 50 and 52, and can prevent passage of expandable elements 12 and 14 in their enlarged, hydrated states, thereby reducing migration of medical device 10. For example, when boundary 54 represents the sacrum, medical device 10 can be deployed through a sacral foramen, and expandable elements 12 and 14 can prevent medical device 10 from migrating from the foramen. Deployed in such as fashion, electrodes 18 and 20 deployed on medical device 10 can be configured to sense or stimulate sacral nerves, e.g., for neurostimluation therapy for sexual dysfunction or urinary or fecal incontinence.
FIGS. 4 and 5 also depict deployment of medical device 60, which is another embodiment of the invention. Medical device 60 is similar to medical device 10 in some respects. Medical device 10 includes one non-expandable element 16 and two expandable elements 12 and 14, and medical device 60 includes two non-expandable elements 62 and 64, with three expandable elements 66, 68 and 70. Like medical device 10, medical device 60 is substantially cylindrical. As shown in FIGS. 4 and 5, however, medical device 60 defines a smaller diameter than medical device 10. Medical device 60 can be deployed through a catheter, a cannula or other medical instruments.
As shown in FIG. 5, expandable elements 66, 68 and 70 have expanded to a hydrated state when placed in contact with the body fluids present in the tissues. Expandable elements 66, 68 and 70 may be, but need not be, the same size as one another when in the hydrated state. As shown in FIG. 5, for example, expandable element 70, when in the hydrated state, is smaller than expandable elements 66, and 68. Expandable elements 68 and 70 can include central apertures to permit passage of electrical components such as lead wires. The materials used to make medical device 60 may be the same as the materials used to make medical device 10. In some embodiments of the invention, first non- expandable element 62 may be constructed of a first material, such as polyurethane, and second non-expandable element 64 may be constructed from a second material, such as silicone
Medical device 60 includes a lead 74. Lead 74 can be coupled to non-expandable element 64 through a central aperture in expandable element 70. Lead 74 includes one or more conductors that are electrically coupled to electrodes 76, 78, 80 and 82. The conductors can further be electrically coupled to an implantable medical device (not shown). One example of such an implantable medical device is an implantable pulse generator, which generates stimulating pulses. The stimulating pulses can be delivered to tissue via electrodes 76, 78, 80 and 82. Another example of such an implantable medical device is a sensor that senses electrical parameters, temperature, or other physiological aspects.
FIGS. 6 and 7 depict another embodiment of an exemplary medical device 90 configured to be implanted in a human or animal body. Medical device 90 is similar to medical device 10 shown in FIGS. 1 and 2, in that medical device 90 includes an elongated non-expandable element 92 and two expandable elements 94 and 96. In the embodiment shown in FIGS. 6 and 7, medical device 90 also includes stimulating elements such as electrodes 98 and 100. The materials used to make medical device 10 could also be used to make medical device 90.
Exemplary medical device 90 is shown in FIG. 6 in a miniature configuration, and is shown in FIG. 7 in an expanded configuration. In the miniature configuration, medical device 90 has a shape and dimensions comparable to that of a medical device 10 shown in FIG. 1. When implanted in a body of a patient, expandable elements 94 and 96 swell radially when placed in contact with bodily fluids, and device 90 assumes an expanded configuration. In the expanded configuration, expandable elements 94 and 96 have a larger perimeter, giving medical device 90 a modified dumbbell shape. Expandable elements 94 and 96 include a plurality of projections 102, 104 separated by gaps.
Expandable elements 94 and 96 can be prepared in a number of ways. One technique is to shape expandable elements 94 and 96 when expandable elements 94 and 96 are in the expanded hydrated state, then desiccate expandable elements 94 and 96 to put them in a dehydrated state and thereby reduce their size. Molding and cutting are two exemplary techniques for shaping expandable elements 94 and 96.
Multiple projections may offer one or more advantages. For example, gaps between projections 102, 104 can facilitate flow of fluid in some deployments. In other deployments, cells such as fibroblasts and fibrous tissue can occupy the gaps, thereby anchoring expandable elements 94 and 96 more firmly.
FIG. 8 is a block diagram of an exemplary medical device 110 that can employ many of the features described above. Medical device 110 is an example of a self- contained implantable stimulator. Stimulator 110 includes pulse generator 112, which supplies electrical stimulations to the target tissue via electrodes 114, 116, which are exposed to the tissue. Pulse generator 112 supplies stimulations under the direction of processor 118. Processor 118 may comprise a microprocessor, application specific integrated circuit, a programmable logic chip, or other controlling circuitry.
A power supply 120, such as a capacitor or a battery, supplies power to pulse generator 112 and processor 1 18. In the embodiment depicted in FIG. 8, medical device 110 includes an inductive coil 122 configured to receive energy from an external energy source. Medical device 1 10 also includes a wireless telemetry interface 124 configured to wirelessly transmit or receive data or instructions. Pulse generator 112, processor 118, power supply 120, coil 122 and wireless telemetry interface 124 are housed inside non- expandable element 126.
Expandable elements 128, 130 expand from a dehydrated state to a hydrated state when medical device 1 10 is implanted in the body of a patient. Expansion of expandable elements 128, 130 restricts migration of medical device 110. As a result, electrodes 114, 116 tend to remain proximate to the target tissue.
Medical device 110 can include components other than or in addition to the components depicted in FIG. 8. For example, medical device 1 10 can incorporate an accelerometer or a sensor, such as a sensor configured to sense conditions such as pressure, flow, temperature, fluid level, contractile force, pH or chemical concentration. The invention is not limited to the specific embodiment depicted in FIG. 8.
In addition, FIG. 8 depicts electronic components such as electrodes as housed inside non-expandable element 126. The invention also supports embodiments in which one or more components are deployed on or in expandable elements 128, 130. For example, an electrode can be deployed on the surface of an expandable element such that the electrode moves away from non-expandable element 126 when the expandable element expands.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood, therefore, that other expedients known to those skilled in the art or disclosed herein may be employed without departing from the invention or the scope of the appended claims. For example, the invention is not limited to an implant having the shape and illustrative dimensions described above.
Furthermore, the invention is not limited to the particular shapes of expandable elements depicted in the figures. As shown in FIGS. 1, 2, 6 and 7, the expandable elements have substantially circular perimeters, and the perimeters expand as the expandable elements assume the hydrated state. In some embodiments, the perimeters of the expandable elements can by substantially elliptical or triangular, for example. In addition, the invention encompasses embodiments in which the expandable elements expand further in one direction than in another. The invention also encompasses embodiments in which one or more expandable element is folded or rolled to reduce its profile in the dehydrated state. As such an expandable element expands, the expandable element automatically unfolds or unrolls.
Although the invention is described as useful in application with the neurostimulation, the invention is not limited to that application. Furthermore, the invention can be deployed via implantation techniques in addition to those described above. The invention further includes within its scope methods of making and using the implants described above.
In the appended claims, means-plus-function clauses are intended to cover the structures described herein as performing the recited function and not only structural equivalents but also equivalent structures. Thus, although a nail and a screw may not be structural equivalents in that a nail employs a cylindrical surface to secure wooden parts together, whereas a screw employs a helical surface, in the environment of fastening wooden parts a nail and a screw are equivalent structures.

Claims

CLAIMS:
1. An implantable medical device comprising: a non-expandable element; and a hydrogel element coupled to the non-expandable element; wherein the hydrogel element has a first perimeter in a dehydrated state and a second perimeter in a hydrated state, and wherein the hydrogel element is configured to expand from the first perimeter to the second perimeter when the hydrogel element is in contact with a body fluid of a patient.
2. The device of claim 1, wherein the hydrogel element is a first hydrogel element, the device further comprising a second hydrogel element coupled to the non-expandable element and configured to expand from a dehydrated state to a hydrated state.
3. The device of claim 2, wherein the non-expandable element has a proximal end and a distal end, wherein the first hydrogel element is coupled to the proximal end, and the second hydrogel element is coupled to the distal end.
4. The device of claim 1, wherein the non-expandable element is constructed of at least one of polyurethane, silicone, titanium, stainless steel, fluoropolymer or hydrogel.
5. The device of claim 1, wherein the non-expandable element is substantially cylindrical and has a diameter from approximately one millimeter to approximately seven millimeters.
6. The device of claim 1, wherein the length of the device is from ten millimeters to twenty millimeters.
7. The device of claim 1, wherein the second perimeter is approximately two times to five times larger than the first perimeter.
8. The device of claim 1 , further comprising an electrode coupled to the non- expandable element.
9. The device of claim 8, further comprising a lead comprising a conductor electrically coupled to the electrode.
10. The device of claim 8, further comprising a power supply coupled to the electrode.
11. The device of claim 8, further comprising a pulse generator coupled to the electrode
12. The device of claim 1 1, wherein the pulse generator is housed inside the non- expandable element.
13. The device of claim 1, wherein the non-expandable element is a first non- expandable element and wherein the hydrogel element is a first hydrogel element, the device further comprising: a second non-expandable element coupled to the first hydrogel element; and a second hydrogel element coupled to the second non-expandable element.
14. The device of claim 1, further such as a sensor coupled to the non-expandable element, wherein the sensor is configured to sense at least one of pressure, flow, temperature, fluid level, contractile force, pH or chemical concentration.
15. An implantable electrical stimulation device comprising: a non-expandable element housing an implantable pulse generator; and a hydrogel element coupled to the non-expandable element; wherein the hydrogel element is configured to expand from a dehydrated state to a hydrated state.
16. The device of claim 15, further comprising a processor configured to control the pulse generator, wherein the non-expandable element houses the processor.
17. The device of claim 15, further comprising a lead comprising a conductor electrically coupled to the pulse generator.
18. The device of claim 15, further comprising a power supply electrically coupled to the pulse generator.
19. The device of claim 15, wherein the non-expandable element is substantially cylindrical and has a diameter from approximately one millimeter to approximately seven millimeters.
20. The device of claim 15, wherein the length of the device is from ten millimeters to twenty millimeters.
21. The device of claim 15, wherein the hydrogel element is configured to expand in dimension approximately two times to five times when expanding from the dehydrated state to the hydrated state.
22. A method comprising: providing a non-expandable element; and coupling a hydrogel element to the non-expandable element, wherein the hydrogel element has a first perimeter in a dehydrated state and a second perimeter in a hydrated state, and wherein the hydrogel element is configured to expand from the first perimeter to the second perimeter when the hydrogel element is in contact with a body fluid of a patient.
23. The method of claim 22, further comprising coupling the non-expandable element to a lead.
24. The method of claim 22, wherein the lead comprises a conductor, further comprising coupling an electrode to the non-expandable element and coupling the electrode to the conductor.
25. The method of claim 22, wherein the non-expandable element is substantially cylindrical and has a diameter from approximately one millimeter to approximately seven millimeters.
26. The method of claim 22, wherein the length of the device is from ten millimeters to twenty millimeters.
27. The method of claim 22, wherein the hydrogel element is configured such that the second perimeter is approximately two times to five times larger than the first perimeter.
28. An implantable medical device comprising: non-expandable element means; and expandable element means coupled to the non-expandable element means; wherein the expandable element means is configured to expand from a first perimeter to a second perimeter when the expandable element means is in contact with a body fluid of a patient.
29. The device of claim 28, further comprising an electrode means coupled to the non- expandable element means.
30. The device of claim 29, further comprising a stimulating means coupled to the electrode means.
31. The device of claim 28, wherein the device is a substantially rice-shaped device prior to expansion of the expandable element means from the first perimeter to the second perimeter.
32. The device of claim 28, wherein the device is a substantially dumbbell-shaped device after the expansion of the expandable element means from the first perimeter to the second perimeter.
33. The device of claim 28, wherein the non-expandable element means is substantially cylindrical and has a diameter from approximately one millimeter to approximately seven millimeters.
34. The device of claim 28, wherein the length of the device is from ten millimeters to twenty millimeters.
35. The device of claim 28, wherein the expandable element means is configured such that the second perimeter is approximately two times to five times larger than the first perimeter.
36. A method for implanting a medical device, comprising: placing a medical device into a bore of an insertion device, the medical device including a non-expandable element and a hydrogel element coupled to the non- expandable element, the hydrogel element being in a dehydrated state; inserting the insertion device into the body of a patient; and ejecting the medical device from the insertion device proximate to a target tissue, wherein the hydrogel element is configured to expand from the first perimeter to the second perimeter when the hydrogel element is ejected from the insertion device.
37. The method of claim 36, wherein the medical device comprises an implantable neurostimulator.
38. The method of claim 36, wherein the medical device comprises an implantable physiological sensor.
39. The method of claim 36, wherein the insertion device comprises one of a needle, a hollow trocar, an endoscope, a catheter or a cannula.
40. An implantable electrical stimulation device comprising: a non -expandable element housing a sensor; and a hydrogel element coupled to the non-expandable element; wherein the hydrogel element is configured to expand from a dehydrated state to a hydrated state.
41. The device of claim 40, wherein the sensor is configured to sense at least one of pressure, flow, temperature, fluid level, contractile force, pH or chemical concentration.
42. The device of claim 40, further comprising a lead comprising a conductor electrically coupled to the sensor.
43. The device of claim 40, wherein the non-expandable element is substantially cylindrical and has a diameter from approximately one millimeter to approximately seven millimeters.
44. The device of claim 40, wherein the length of the device is from ten millimeters to twenty millimeters.
45. The device of claim 40, wherein the hydrogel element is configured to expand in dimension approximately two times to five times when expanding from the dehydrated state to the hydrated state.
PCT/US2005/038157 2004-10-29 2005-10-25 Expandable fixation mechanism WO2006049926A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/977,500 US8489189B2 (en) 2004-10-29 2004-10-29 Expandable fixation mechanism
US10/977,500 2004-10-29

Publications (1)

Publication Number Publication Date
WO2006049926A1 true WO2006049926A1 (en) 2006-05-11

Family

ID=35788993

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/038157 WO2006049926A1 (en) 2004-10-29 2005-10-25 Expandable fixation mechanism
PCT/US2005/038420 WO2006049964A1 (en) 2004-10-29 2005-10-25 Expandable fixation mechanism

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2005/038420 WO2006049964A1 (en) 2004-10-29 2005-10-25 Expandable fixation mechanism

Country Status (2)

Country Link
US (2) US8489189B2 (en)
WO (2) WO2006049926A1 (en)

Families Citing this family (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7747322B2 (en) * 2001-05-01 2010-06-29 Intrapace, Inc. Digestive organ retention device
US7643887B2 (en) * 2001-05-01 2010-01-05 Intrapace, Inc. Abdominally implanted stimulator and method
US7979127B2 (en) * 2001-05-01 2011-07-12 Intrapace, Inc. Digestive organ retention device
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US7689284B2 (en) * 2001-05-01 2010-03-30 Intrapace, Inc. Pseudounipolar lead for stimulating a digestive organ
US20050143784A1 (en) * 2001-05-01 2005-06-30 Imran Mir A. Gastrointestinal anchor with optimal surface area
US7616996B2 (en) * 2005-09-01 2009-11-10 Intrapace, Inc. Randomized stimulation of a gastrointestinal organ
US6535764B2 (en) * 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
AU2004251673B2 (en) * 2003-06-04 2010-01-28 Synecor Llc Intravascular electrophysiological system and methods
US8239045B2 (en) 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
US7082336B2 (en) * 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
US7747335B2 (en) 2003-12-12 2010-06-29 Synecor Llc Implantable medical device having pre-implant exoskeleton
US7844344B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable lead
US20070106357A1 (en) * 2005-11-04 2007-05-10 Stephen Denker Intravascular Electronics Carrier Electrode for a Transvascular Tissue Stimulation System
JP2009504331A (en) * 2005-08-15 2009-02-05 シネコー・エルエルシー Fixing and removing leads
US7805202B2 (en) * 2005-09-30 2010-09-28 Boston Scientific Neuromodulation Corporation Implantable electrodes and insertion methods and tools
WO2007098200A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
US7881804B2 (en) * 2006-03-15 2011-02-01 Kenergy, Inc. Composite waveform based method and apparatus for animal tissue stimulation
US20070255368A1 (en) * 2006-04-28 2007-11-01 Bonde Eric H Implantable medical electrical stimulation lead with distal fixation and method
US20080039904A1 (en) * 2006-08-08 2008-02-14 Cherik Bulkes Intravascular implant system
US20080091255A1 (en) * 2006-10-11 2008-04-17 Cardiac Pacemakers Implantable neurostimulator for modulating cardiovascular function
US9713706B2 (en) 2006-10-31 2017-07-25 Medtronic, Inc. Implantable medical elongated member including intermediate fixation
US20080103576A1 (en) * 2006-10-31 2008-05-01 Medtronic, Inc. Implantable medical elongated member including expandable fixation member
US20080103572A1 (en) 2006-10-31 2008-05-01 Medtronic, Inc. Implantable medical lead with threaded fixation
US20080140098A1 (en) * 2006-11-15 2008-06-12 Monica Kumar Anastomosis Balloon Configurations and device
US8311633B2 (en) * 2006-12-04 2012-11-13 Synecor Llc Intravascular implantable device having superior anchoring arrangement
US20080147168A1 (en) * 2006-12-04 2008-06-19 Terrance Ransbury Intravascular implantable device having detachable tether arrangement
US7662132B2 (en) * 2007-01-25 2010-02-16 Cardiac Pacemakers, Inc. Expandable member for venous lead fixation
US9044593B2 (en) 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
WO2008137452A1 (en) * 2007-05-04 2008-11-13 Kenergy Royalty Company, Llc Implantable high efficiency digital stimulation device
DE102007026057A1 (en) * 2007-06-01 2008-12-11 Universität Rostock Electrode and measuring device for measuring the electrical activity in an electrically active tissue
US9186089B2 (en) * 2007-09-14 2015-11-17 Medtronic Monitoring, Inc. Injectable physiological monitoring system
WO2009048580A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US20090259280A1 (en) * 2007-10-15 2009-10-15 Kevin Wilkin Electrical stimulation lead with bioerodible anchors and anchor straps
US8364267B2 (en) * 2008-01-28 2013-01-29 Boston Scientific Neuromodulation Corporation Fixation of implantable pulse generators
US9037263B2 (en) 2008-03-12 2015-05-19 Medtronic, Inc. System and method for implantable medical device lead shielding
EP3181191B1 (en) 2008-05-15 2020-03-11 Inspire Medical Systems, Inc. Apparatus for sensing respiratory pressure in an implantable stimulation system
US8126571B2 (en) * 2008-06-23 2012-02-28 Cardiac Pacemakers, Inc. Expandable assembly for cardiac lead fixation
US8160721B2 (en) * 2008-08-15 2012-04-17 Cardiac Pacemakers, Inc. Implantable lead with flexible tip features
BRPI0920548B8 (en) 2008-10-09 2021-06-22 Imthera Medical Inc device to control the position of a patient's tongue
US9186499B2 (en) 2009-04-30 2015-11-17 Medtronic, Inc. Grounding of a shield within an implantable medical lead
WO2010135440A1 (en) * 2009-05-22 2010-11-25 Medtronic, Inc. A cover having self-anchoring protrusions for use with an implantable medical device
WO2010144916A2 (en) * 2009-06-12 2010-12-16 Innerpulse, Inc. Methods and systems for anti-thrombotic intravascular implantable devices
US20110004288A1 (en) * 2009-06-12 2011-01-06 Terrance Ransbury Intravascular implantable device having integrated anchor mechanism
US20110112601A1 (en) 2009-11-10 2011-05-12 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US8948882B2 (en) 2010-08-25 2015-02-03 Medtronic, Inc. Fixation components for implantable medical devices and associated device construction
WO2012045030A2 (en) 2010-10-01 2012-04-05 Intrapace, Inc. Feedback systems and methods to enhance obstructive and other obesity treatments, optionally using multiple sensors
US8676319B2 (en) 2010-10-29 2014-03-18 Medtronic, Inc. Implantable medical device with compressible fixation member
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
EP2640461B1 (en) 2010-11-16 2019-06-19 The Board Of Trustees Of The Leland Stanford Junior University Systems for treatment of dry eye
DE102010055792B4 (en) * 2010-12-23 2013-07-11 Martin Altrock Device for gastrointestinal stimulation
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
US10112045B2 (en) 2010-12-29 2018-10-30 Medtronic, Inc. Implantable medical device fixation
DE102011010575B4 (en) * 2011-02-08 2015-03-05 Arnulf Deinzer Implantable myoelectric muscle stimulator
US20120290053A1 (en) * 2011-05-11 2012-11-15 St. Jude Medical, Inc. Renal nerve stimulation lead, delivery system, and method
US10485435B2 (en) 2012-03-26 2019-11-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter with removeable distal tip
US20130267837A1 (en) * 2012-04-10 2013-10-10 NeuroAccess Technologies Electrical lead positioning systems and methods
WO2013158189A1 (en) 2012-04-19 2013-10-24 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US10463858B2 (en) * 2012-07-17 2019-11-05 Stimwave Technologies Incorporated Devices and methods for treating craniofacial pain
EP2928558B1 (en) 2012-12-07 2017-09-06 Medtronic Inc. Minimally invasive implantable neurostimulation system
US9308022B2 (en) 2012-12-10 2016-04-12 Nevro Corporation Lead insertion devices and associated systems and methods
EP2769750B1 (en) 2013-02-25 2020-01-22 Sorin CRM SAS System for leadless pacing of the heart
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
WO2014172693A2 (en) 2013-04-19 2014-10-23 Oculeve, Inc. Nasal stimulation devices and methods
US10071243B2 (en) 2013-07-31 2018-09-11 Medtronic, Inc. Fixation for implantable medical devices
US10722723B2 (en) 2013-08-16 2020-07-28 Cardiac Pacemakers, Inc. Delivery devices and methods for leadless cardiac devices
US9492674B2 (en) 2013-08-16 2016-11-15 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with delivery and/or retrieval features
US9700732B2 (en) 2013-08-16 2017-07-11 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker and retrieval device
JP6151452B2 (en) 2013-08-16 2017-06-21 カーディアック ペースメイカーズ, インコーポレイテッド Delivery device and method for a leadless heart device
US9393427B2 (en) 2013-08-16 2016-07-19 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with delivery and/or retrieval features
US10179236B2 (en) 2013-08-16 2019-01-15 Cardiac Pacemakers, Inc. Leadless cardiac pacing devices
US9480850B2 (en) 2013-08-16 2016-11-01 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker and retrieval device
US10842993B2 (en) 2013-08-16 2020-11-24 Cardiac Pacemakers, Inc. Leadless cardiac pacing devices
US9993638B2 (en) 2013-12-14 2018-06-12 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
EP3092034B1 (en) 2014-01-10 2019-10-30 Cardiac Pacemakers, Inc. Systems for detecting cardiac arrhythmias
ES2661718T3 (en) 2014-01-10 2018-04-03 Cardiac Pacemakers, Inc. Methods and systems to improve communication between medical devices
EP3110405B1 (en) 2014-02-25 2020-05-06 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9795781B2 (en) 2014-04-29 2017-10-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with retrieval features
WO2015168153A1 (en) 2014-04-29 2015-11-05 Cardiac Pacemakers, Inc. Leadless cardiac pacing devices including tissue engagement verification
WO2016014427A1 (en) 2014-07-23 2016-01-28 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
US10155111B2 (en) 2014-07-24 2018-12-18 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
EP3673952A1 (en) 2014-07-25 2020-07-01 Oculeve, Inc. Stimulation patterns for treating dry eye
WO2016025910A1 (en) * 2014-08-15 2016-02-18 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indications
WO2016027192A1 (en) 2014-08-21 2016-02-25 Koninklijke Philips N.V. A tongue advancer implant or removal tool for a tongue manipulation system
US9526909B2 (en) 2014-08-28 2016-12-27 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
AU2015335776B2 (en) 2014-10-22 2020-09-03 Oculeve, Inc. Stimulation devices and methods for treating dry eye
WO2016065211A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Contact lens for increasing tear production
EP3209371A4 (en) 2014-10-22 2018-10-24 Oculeve, Inc. Implantable nasal stimulator systems and methods
EP3253449B1 (en) 2015-02-06 2018-12-12 Cardiac Pacemakers, Inc. Systems for safe delivery of electrical stimulation therapy
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016141046A1 (en) 2015-03-04 2016-09-09 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
EP3294408B1 (en) * 2015-05-13 2021-08-25 Medtronic, Inc. Securing an implantable medical device in position while reducing perforations
US20160361535A1 (en) * 2015-06-11 2016-12-15 Micron Devices Llc Embedded fixation devices or leads
WO2016209240A1 (en) * 2015-06-25 2016-12-29 Medivators Inc. Expandable fitting for a medical scoping device
US10357159B2 (en) 2015-08-20 2019-07-23 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
CN108136186B (en) 2015-08-20 2021-09-17 心脏起搏器股份公司 System and method for communication between medical devices
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10159842B2 (en) 2015-08-28 2018-12-25 Cardiac Pacemakers, Inc. System and method for detecting tamponade
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
US10099050B2 (en) 2016-01-21 2018-10-16 Medtronic, Inc. Interventional medical devices, device systems, and fixation components thereof
US10463853B2 (en) 2016-01-21 2019-11-05 Medtronic, Inc. Interventional medical systems
US10350423B2 (en) 2016-02-04 2019-07-16 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
EP3432975B1 (en) 2016-03-21 2024-02-14 Nalu Medical, Inc. Devices for positioning external devices in relation to implanted devices
CN108883286B (en) 2016-03-31 2021-12-07 心脏起搏器股份公司 Implantable medical device with rechargeable battery
CA3022683A1 (en) 2016-05-02 2017-11-09 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
WO2018009569A1 (en) 2016-07-06 2018-01-11 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
WO2018017463A1 (en) 2016-07-18 2018-01-25 Nalu Medical, Inc. Methods and systems for treating pelvic disorders and pain conditions
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10391319B2 (en) 2016-08-19 2019-08-27 Cardiac Pacemakers, Inc. Trans septal implantable medical device
US10870008B2 (en) 2016-08-24 2020-12-22 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
US10780278B2 (en) 2016-08-24 2020-09-22 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
US10994145B2 (en) 2016-09-21 2021-05-04 Cardiac Pacemakers, Inc. Implantable cardiac monitor
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
US10758724B2 (en) 2016-10-27 2020-09-01 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
JP7038115B2 (en) 2016-10-27 2022-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with pressure sensor
WO2018081275A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
WO2018081721A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
CN109890456B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
CN109963618B (en) 2016-11-21 2023-07-04 心脏起搏器股份公司 Leadless cardiac pacemaker with multi-mode communication
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
US11147979B2 (en) 2016-11-21 2021-10-19 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
RU2019118600A (en) 2016-12-02 2021-01-11 Окулив, Инк. APPARATUS AND METHOD FOR MAKING DRY EYE SYNDROME PREDICTION AND TREATMENT RECOMMENDATIONS
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
EP3573706A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
US10737102B2 (en) 2017-01-26 2020-08-11 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
EP3585475B1 (en) 2017-02-24 2024-04-03 Nalu Medical, Inc. Apparatus with sequentially implanted stimulators
AU2018231031B2 (en) 2017-03-09 2023-11-02 Nevro Corp. Paddle leads and delivery tools, and associated systems and methods
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
EP3621689A4 (en) 2017-05-09 2021-01-27 Nalu Medical, Inc. Stimulation apparatus
WO2018209031A2 (en) * 2017-05-11 2018-11-15 Medivators Inc. Fitting for a medical scoping device having a plurality of protuberances and tab
US11116966B2 (en) * 2017-08-17 2021-09-14 Cardiac Pacemakers, Inc. Retention mechanism for an implantable lead
WO2019036600A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
CN111107899B (en) 2017-09-20 2024-04-02 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
EP3717060B1 (en) 2017-12-01 2022-10-05 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
EP3717063B1 (en) 2017-12-01 2023-12-27 Cardiac Pacemakers, Inc. Systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
EP3717059A1 (en) 2017-12-01 2020-10-07 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
CN111556773A (en) 2018-01-04 2020-08-18 心脏起搏器股份公司 Dual chamber pacing without beat-to-beat communication
EP3755418B1 (en) 2018-02-22 2023-06-21 Axonics, Inc. Neurostimulation leads for trial nerve stimulation
CN111886046A (en) 2018-03-23 2020-11-03 美敦力公司 AV-synchronized VFA cardiac therapy
WO2019183512A1 (en) 2018-03-23 2019-09-26 Medtronic, Inc. Vfa cardiac resynchronization therapy
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
AU2019242906A1 (en) 2018-03-29 2020-10-15 Nevro Corp. Leads having sidewall openings, and associated systems and methods
DE102018111741A1 (en) * 2018-05-16 2019-11-21 Biotronik Se & Co. Kg Passive fixation of an implantable electrode lead by means of compressible anchoring elements
CN110870948B (en) 2018-08-31 2021-11-05 创领心律管理医疗器械(上海)有限公司 Delivery device, cardiac pacing device and fixing structure thereof
EP3856331A1 (en) 2018-09-26 2021-08-04 Medtronic, Inc. Capture in ventricle-from-atrium cardiac therapy
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11759632B2 (en) 2019-03-28 2023-09-19 Medtronic, Inc. Fixation components for implantable medical devices
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
WO2020205401A1 (en) 2019-03-29 2020-10-08 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2020205397A1 (en) 2019-03-29 2020-10-08 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11065461B2 (en) 2019-07-08 2021-07-20 Bioness Inc. Implantable power adapter
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11571582B2 (en) 2019-09-11 2023-02-07 Cardiac Pacemakers, Inc. Tools and systems for implanting and/or retrieving a leadless cardiac pacing device with helix fixation
EP4028116A1 (en) 2019-09-11 2022-07-20 Cardiac Pacemakers, Inc. Tools and systems for implanting and/or retrieving a leadless cardiac pacing device with helix fixation
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11389647B2 (en) 2020-02-03 2022-07-19 Nevro Corp. Neurological stimulation lead anchors and associated tools, and methods
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation
WO2023242367A1 (en) * 2022-06-15 2023-12-21 Capri Medical Limited Neural implant system and method

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269198A (en) 1979-12-26 1981-05-26 Medtronic, Inc. Body implantable lead
US4943618A (en) 1987-12-18 1990-07-24 Kingston Technologies Limited Partnership Method for preparing polyacrylonitrile copolymers by heterogeneous reaction of polyacrylonitrile aquagel
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5252692A (en) 1990-11-23 1993-10-12 Kingston Technologies, Inc. Hydrophilic acrylic copolymers and method of preparation
US5405367A (en) 1991-12-18 1995-04-11 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US20020016622A1 (en) * 1998-08-12 2002-02-07 Cardiac Pacemakers, Inc. Expandable seal for use with medical device and system
US20030229303A1 (en) * 2002-03-22 2003-12-11 Haffner David S. Expandable glaucoma implant and methods of use
US6704605B2 (en) 2002-01-31 2004-03-09 Cardiac Pacemakers, Inc. Medical electrode assembly

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3811423A (en) * 1971-01-22 1974-05-21 Agrophysics Inc Device for insertion into the reproductive tract and method of using same
US3902501A (en) * 1973-06-21 1975-09-02 Medtronic Inc Endocardial electrode
US4768523A (en) * 1981-04-29 1988-09-06 Lifecore Biomedical, Inc. Hydrogel adhesive
DE3415410C2 (en) * 1983-04-19 1995-10-05 Biotronik Mess & Therapieg Pacemaker electrode
US4658835A (en) * 1985-07-25 1987-04-21 Cordis Corporation Neural stimulating lead with fixation canopy formation
US5190052A (en) * 1990-11-21 1993-03-02 Intermedics, Inc. Pacer lead with bipolar electrode
US5300107A (en) * 1992-10-22 1994-04-05 Medtronic, Inc. Universal tined myocardial pacing lead
US5545206A (en) * 1994-12-22 1996-08-13 Ventritex, Inc. Low profile lead with automatic tine activation
US5662698A (en) * 1995-12-06 1997-09-02 Ventritex, Inc. Nonshunting endocardial defibrillation lead
US5658327A (en) * 1995-12-19 1997-08-19 Ventritex, Inc. Intracardiac lead having a compliant fixation device
FR2742995B1 (en) * 1995-12-29 1998-03-06 Ela Medical Sa PROBE FOR IMPLANTED MEDICAL DEVICE, PARTICULARLY FOR HEART STIMULATOR
IL118352A0 (en) * 1996-05-21 1996-09-12 Sudai Amnon Apparatus and methods for revascularization
US6164284A (en) * 1997-02-26 2000-12-26 Schulman; Joseph H. System of implantable devices for monitoring and/or affecting body parameters
US6086582A (en) * 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US6324415B1 (en) * 1997-07-30 2001-11-27 Intermedics Inc. Cardiac lead with minimized inside diameter of sleeve
US5908447A (en) 1998-02-06 1999-06-01 Intermedics Inc. Breakaway structure for body implantable medical device
US5957966A (en) * 1998-02-18 1999-09-28 Intermedics Inc. Implantable cardiac lead with multiple shape memory polymer structures
US5951597A (en) * 1998-04-14 1999-09-14 Cardiac Pacemakers, Inc. Coronary sinus lead having expandable matrix anchor
US6161047A (en) * 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6240322B1 (en) * 1998-11-04 2001-05-29 Cardiac Pacemakers, Inc. System and apparatus having low profile collapsible tines
ES2230826T3 (en) * 1999-04-02 2005-05-01 Sorin Biomedica Crm S.R.L. ANCHORAGE STRUCTURE FOR IMPLANTABLE ELECTRODES.
US6542776B1 (en) * 1999-04-14 2003-04-01 Transneuronix Inc. Gastric stimulator apparatus and method for installing
AU6953300A (en) * 1999-07-07 2001-01-22 Cardiac Pacemakers, Inc. Endocardial electrode assembly having conductive fixation features
US6434431B1 (en) * 2000-01-20 2002-08-13 Medtronic, Inc. Intramuscular medical electrical lead with fixation member
US6510347B2 (en) * 2000-08-17 2003-01-21 William N. Borkan Spinal cord stimulation leads
US6783499B2 (en) * 2000-12-18 2004-08-31 Biosense, Inc. Anchoring mechanism for implantable telemetric medical sensor
SE0004765D0 (en) * 2000-12-20 2000-12-20 St Jude Medical An electrode head fixation arrangement
US6697676B2 (en) * 2000-12-21 2004-02-24 Medtronic, Inc. Medical electrical lead having an expandable electrode assembly
US7292890B2 (en) * 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US20040230282A1 (en) * 2003-04-11 2004-11-18 Cates Adam W. Acute and chronic fixation for subcutaneous electrodes
US7349742B2 (en) * 2003-04-11 2008-03-25 Cardiac Pacemakers, Inc. Expandable fixation elements for subcutaneous electrodes
US7177702B2 (en) * 2004-03-12 2007-02-13 Scimed Life Systems, Inc. Collapsible/expandable electrode leads
US7747333B2 (en) * 2004-08-16 2010-06-29 Cardiac Pacemakers, Inc. Lead assembly and methods including a push tube
US20060095077A1 (en) * 2004-10-29 2006-05-04 Tronnes Carole A Expandable fixation structures

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269198A (en) 1979-12-26 1981-05-26 Medtronic, Inc. Body implantable lead
US4943618A (en) 1987-12-18 1990-07-24 Kingston Technologies Limited Partnership Method for preparing polyacrylonitrile copolymers by heterogeneous reaction of polyacrylonitrile aquagel
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5252692A (en) 1990-11-23 1993-10-12 Kingston Technologies, Inc. Hydrophilic acrylic copolymers and method of preparation
US5405367A (en) 1991-12-18 1995-04-11 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US20020016622A1 (en) * 1998-08-12 2002-02-07 Cardiac Pacemakers, Inc. Expandable seal for use with medical device and system
US6704605B2 (en) 2002-01-31 2004-03-09 Cardiac Pacemakers, Inc. Medical electrode assembly
US20030229303A1 (en) * 2002-03-22 2003-12-11 Haffner David S. Expandable glaucoma implant and methods of use

Also Published As

Publication number Publication date
US20130296957A1 (en) 2013-11-07
US20060095078A1 (en) 2006-05-04
WO2006049964A1 (en) 2006-05-11
US8489189B2 (en) 2013-07-16

Similar Documents

Publication Publication Date Title
US20060095077A1 (en) Expandable fixation structures
WO2006049926A1 (en) Expandable fixation mechanism
US11013911B2 (en) Lead positioning and finned fixation system
US10981002B2 (en) Intercostal muscle fixation for an implanted medical device
US8036756B2 (en) Implantable medical electrical stimulation lead fixation method and apparatus
EP2086630B1 (en) Implantable medical elongated member including expandable fixation members
US7904175B2 (en) Trans-esophageal vagus nerve stimulation
US8509917B2 (en) Anchoring units for leads of implantable electric stimulation systems and methods of making and using
US7869884B2 (en) Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US8285397B2 (en) System and method for lead fixation
US7627383B2 (en) Implantable stimulator
US8457763B2 (en) Implantable medical electrical stimulation lead fixation method and apparatus
US20060247720A1 (en) Intra-luminal device for gastrointestinal stimulation
US9095700B2 (en) Lead positioning and fixation system
WO2003099375A2 (en) Adjustable implantable captivation fixation anchor-stop
US9220887B2 (en) Electrode lead including a deployable tissue anchor
US8442649B2 (en) Systems and methods for anchoring leads of electrical stimulation systems in and around bony structures
US11918802B2 (en) Foramina-filling implantable medical lead
US20210085966A1 (en) Implantable medical lead including fixation ridge
CA2685028A1 (en) Non-surgical device and methods for trans-esophageal vagus nerve stimulation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05812231

Country of ref document: EP

Kind code of ref document: A1